28 September 2026
A breakthrough study from the University of British Columbia reveals that novel mutations identified in a critically ill Canadian patient severely diminished the H5N1 virus's ability to bind host receptors, overturning initial fears of enhanced human adaptation.
The Paradox: When Concerning Mutations Weaken Attachment
When an adolescent in British Columbia was hospitalized in November 2024 with acute respiratory failure from H5N1 avian influenza, Canada's first domestic human infection, global public health authorities sounded alarms. Genomic sequencing of the virus (designated BC24, clade 2.3.4.4b) identified two prominent mutations in the hemagglutinin (HA) surface protein: E190D and Q226H. Because modifications at these precise positions historically enabled avian viruses to switch specificity to human-type -linked sialic acid receptors, virologists feared the virus was actively adapting to spread efficiently among humans.
A multi-disciplinary research team led by Dr. Sriram Subramaniam at the University of British Columbia (UBC) analyzed these viral variants at the molecular and cellular levels. Published in Nature Communications, their investigation uncovered a startling paradox: rather than enhancing human affinity, the mutations severely compromised the virus's ability to bind both human and avian cell receptors.
To understand how the mutated hemagglutinin behaves, the researchers deployed cryogenic electron microscopy (cryo-EM), glycan microarrays, and cell-fusion assays:
- An Empty Receptor Pocket: In classic avian strains and recent dairy cattle isolates, an internal sugar called an "auto-glycan" naturally sits inside the HA receptor-binding site. In the cryo-EM structures of BC24, this auto-glycan was completely missing. The E190D mutation shortened the amino acid side chain, pulling its carboxyl group 4.9 Å away from the critical binding point, while the Q226H mutation tilted outward by 1.1 Å, disrupting the essential chemical interactions required to latch onto host sugars.
- Complete Loss of Measurable Sialoside Binding: On comprehensive glycan microarrays and quantitative ELISA assays, BC24 HA showed no detectable attachment to human-type (α2,6) or avian-type (α2,3) receptors. Testing single-mutant variations proved that E190D and Q226H each independently cripple receptor binding, dispelling the theory that the virus had gained human-like tropism.
- Membrane Fusion Driven by Collective Strength (Avidity): If the virus attaches so poorly, how did it infect a human lung cell? The team conducted cell-to-cell fusion assays in human alveolar cells. Despite undetectable binding on static arrays, the full-length BC24 HA successfully triggered membrane fusion under endosomal acidic conditions, albeit at reduced levels (32% of standard control). This confirms that a high concentration of viral proteins acting together (an avidity effect) can overcome weak individual binding to achieve cellular entry.
Clinical Significance: Bypassing Upper Defenses to Reach the Deep Lung
The fact that a virus with impaired binding caused life-threatening illness yields a vital insight into respiratory pathogenesis. The UBC researchers hypothesize that because the BC24 variant lacked strong binding to the sugars lining the nose and throat, it avoided entrapment in the upper respiratory mucus layer. This allowed virions to bypass primary barriers and penetrate deeply into the lower respiratory tract and alveoli, where avian influenza produces severe tissue destruction and hyper-inflammatory cytokine cascades. Tracheal aspirate samples from the patient confirmed higher viral loads and longer shedding periods than throat swabs, supporting this deep-lung localization.
Ni et al. (2026). Diminished sialoside binding in novel H5N1 influenza hemagglutinin variants identified in a human patient. Nature Communications, 17, 9972.
